Search - tctmd.com

Displaying 1 - 20 of 1512

Sort: Relevancy | Date

News Conference News TCT 2025

At 3 Years, DCBs Still Less Safe Than DES in De Novo CAD: REC-CAGEFREE I

Yael L. Maxwell

November 07, 2025

News Conference News TCT 2025

Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2

Todd Neale

November 03, 2025

News Industry News

SMT’s Supraflex Cruz Shows Consistent and Robust Clinical Outcomes Across Key Global Studies Presented at TCT 2025

October 29, 2025

Presentation TCT 2025

Randomized Comparison of the Supraflex CruzTM vs. SYNERGYTM Drug-Eluting Stents: The Multivessel TALENT Randomized Trial

Presenter: Patrick W. Serruys

October 28, 2025

Presentation TCT 2025

TCT 513: Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Treatment for Single De Novo Diffuse Coronary Lesions

Presenter: Eun-Seok Shin

October 28, 2025

Presentation TCT 2025

TCT 963: Ethnic Disparities in Inflammatory Phenotype and CV Outcomes After Drug-Eluting Stent Implantation: A Multiethnic Perspective

Presenter: Kyung-Taek Park

October 28, 2025

Presentation TCT 2025

TCT 245: Final 7-Year Results from the COMPARE-ABSORB Trial: Randomized Comparison of Bioresorbable Vascular Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis. Detailed analysis of long lesions

Presenter: Robert-Jan Van Geuns

October 28, 2025

Presentation TCT 2025

TCT 619: Validation of Novel Endpoint for Optimal Drug-eluting stent Implantation in Patients with Acute Coronary Syndrome

Presenter: Hisaki Masuda

October 28, 2025

Presentation TCT 2025

TCT 518: Impact of Left Ventricular Ejection Fraction on Outcomes with Drug-Coated Balloon versus Drug-Eluting Stent for de novo Coronary Artery Disease: Insights from the REC-CAGEFREE I Trial

Presenter: Bo Song

October 28, 2025

Presentation TCT 2025

TCT 1654: Coronary Pseudoaneurysm due to Drug Eluting Stent

Presenter: Saroj Kumar Sahoo

October 28, 2025

Presentation TCT 2025

TCT 468: Comparison of Limus and Paclitaxel Drug-Coated Balloons, 2nd-generation or Newer Drug-Eluting Stents, and Balloon Angioplasty: A Network Meta-Analysis of Randomized Controlled Trials

Presenter: Yuko Kiyohara

October 27, 2025

Presentation TCT 2025

TCT 945: The TASMAN Study: Third (3G) Alongside Second (2G) Generation Drug Eluting Stent (DES) and overall MACCE At Nepean: Insights from a large west of Sydney Tertiary centre during the Transition from 2G to 3G DES.

Presenter: Robert T. Gerber

October 27, 2025

Presentation TCT 2025

TCT 592: INTRAVASCULAR ULTRASOUND-GUIDED DRUG ELUTING STENTING FOR RENAL ARTERY STENOSIS: SINGLE CENTER PILOT STUDY 2017-2023

Presenter: Muhammad Haisum Maqsood

October 27, 2025

Presentation TCT 2025

Long Term Clinical Outcomes in Patients Treated with the Bioadaptor Compared with a Contemporary Drug Eluting Stent: The INFINITY-SWEDEHEART Randomized Trial

Presenter: David Erlinge

October 27, 2025

Presentation TCT 2025

TCT 910: Novel Hybrid Drug-Eluting BioStealth™ Stent for Below-the-Knee Lesions: Preclinical Results and Proposed Pivotal Clinical Trial

Presenter: Terumitsu Hasebe

October 27, 2025

Presentation TCT 2025

TCT 95: IVUS-Guided Drug-Eluting Stent Implantation in Patients With Coronary Artery Disease and Chronic Kidney Disease

Presenter: Xiaofei Gao

October 27, 2025

Presentation TCT 2025

TCT 511: Paclitaxel-Coated Balloons versus Newer-Generation Drug-Eluting Stents for De Novo Coronary Artery Lesions: A Meta-Analysis of Randomized Controlled Trials

Presenter: Kamil Bujak

October 27, 2025

Presentation TCT 2025

TCT 508: Drug-Coated Balloon Versus Drug-Eluting Stent in De Novo Large Coronary Artery Disease: A Systematic Review and Meta-analysis.

Presenter: Mohamed Elnady

October 27, 2025

Presentation TCT 2025

TCT 509: Drug-Coated Balloon Versus Drug-Eluting Stent in De Novo Small Coronary Artery Disease: A Systematic Review and Meta-Analysis

Presenter: Mohamed Elnady

October 27, 2025

Presentation TCT 2025

TCT 502: Drug-Coated Balloons Versus Drug-Eluting Stents for Patients with Diffuse De Novo Coronary Artery Lesions: Insights from the REC-CAGEFREE I Trial

Presenter: Yuehao Lv

October 27, 2025

Advertisement

At 3 Years, DCBs Still Less Safe Than DES in De Novo CAD: REC-CAGEFREE I

Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2

SMT’s Supraflex Cruz Shows Consistent and Robust Clinical Outcomes Across Key Global Studies Presented at TCT 2025

Randomized Comparison of the Supraflex CruzTM vs. SYNERGYTM Drug-Eluting Stents: The Multivessel TALENT Randomized Trial

TCT 513: Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Treatment for Single De Novo Diffuse Coronary Lesions

TCT 963: Ethnic Disparities in Inflammatory Phenotype and CV Outcomes After Drug-Eluting Stent Implantation: A Multiethnic Perspective

TCT 245: Final 7-Year Results from the COMPARE-ABSORB Trial: Randomized Comparison of Bioresorbable Vascular Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis. Detailed analysis of long lesions

TCT 619: Validation of Novel Endpoint for Optimal Drug-eluting stent Implantation in Patients with Acute Coronary Syndrome

TCT 518: Impact of Left Ventricular Ejection Fraction on Outcomes with Drug-Coated Balloon versus Drug-Eluting Stent for de novo Coronary Artery Disease: Insights from the REC-CAGEFREE I Trial

TCT 1654: Coronary Pseudoaneurysm due to Drug Eluting Stent

TCT 468: Comparison of Limus and Paclitaxel Drug-Coated Balloons, 2nd-generation or Newer Drug-Eluting Stents, and Balloon Angioplasty: A Network Meta-Analysis of Randomized Controlled Trials

TCT 945: The TASMAN Study: Third (3G) Alongside Second (2G) Generation Drug Eluting Stent (DES) and overall MACCE At Nepean: Insights from a large west of Sydney Tertiary centre during the Transition from 2G to 3G DES.

TCT 592: INTRAVASCULAR ULTRASOUND-GUIDED DRUG ELUTING STENTING FOR RENAL ARTERY STENOSIS: SINGLE CENTER PILOT STUDY 2017-2023

Long Term Clinical Outcomes in Patients Treated with the Bioadaptor Compared with a Contemporary Drug Eluting Stent: The INFINITY-SWEDEHEART Randomized Trial

TCT 910: Novel Hybrid Drug-Eluting BioStealth™ Stent for Below-the-Knee Lesions: Preclinical Results and Proposed Pivotal Clinical Trial

TCT 95: IVUS-Guided Drug-Eluting Stent Implantation in Patients With Coronary Artery Disease and Chronic Kidney Disease

TCT 511: Paclitaxel-Coated Balloons versus Newer-Generation Drug-Eluting Stents for De Novo Coronary Artery Lesions: A Meta-Analysis of Randomized Controlled Trials

TCT 508: Drug-Coated Balloon Versus Drug-Eluting Stent in De Novo Large Coronary Artery Disease: A Systematic Review and Meta-analysis.

TCT 509: Drug-Coated Balloon Versus Drug-Eluting Stent in De Novo Small Coronary Artery Disease: A Systematic Review and Meta-Analysis

TCT 502: Drug-Coated Balloons Versus Drug-Eluting Stents for Patients with Diffuse De Novo Coronary Artery Lesions: Insights from the REC-CAGEFREE I Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content